Anavex Life Sciences (AVXL) Current Assets (2011 - 2020)

Anavex Life Sciences (AVXL) has 10 years of Current Assets data on file, last reported at $31.6 million in Q2 2020.

• For the quarter ending Q2 2020, Current Assets rose 44.98% year-over-year to $31.6 million; the trailing twelve-month figure through Jun 2020 stood at $31.6 million (up 44.98% YoY), and the FY2019 full-year result was $25.3 million, down 2.78% from the prior year.
• Current Assets grew to $31.6 million in Q2 2020, from $25.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $31.6 million in Q2 2020 to a low of $9.4 million in Q3 2016.
• A 5-year average of $24.2 million and a median of $25.6 million in 2018 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 194.15% in 2017 and decreased 21.9% in 2018, its largest moves.
• Tracing AVXL's Current Assets over 5 years: stood at $9.4 million in 2016, then surged by 199.5% to $28.3 million in 2017, then dropped by 21.9% to $22.1 million in 2018, then grew by 14.63% to $25.3 million in 2019, then rose by 24.88% to $31.6 million in 2020.
• Business Quant data shows AVXL's Current Assets at $31.6 million in Q2 2020, $25.3 million in Q3 2019, and $21.8 million in Q2 2019.